Abstract
Annual Review of Neuroscience
Vol. 28:
57-87
(Volume publication date July 2005)
(doi:10.1146/annurev.neuro.28.061604.135718)
First published online as a Review in Advance on January 25, 2005MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE Darren J. Moore,1,2 Andrew B. West,1,2 Valina L. Dawson,1,2,3,4 and Ted M. Dawson1,2,31Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; email: dmoore20@jhmi.edu 2Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; email: abwest@jhmi.edu 3Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; email: vdawson@jhmi.edu 4Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; email: tdawson@jhmi.edu Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Although the etiology of PD is incompletely understood, the recent discovery of genes associated with rare monogenic forms of the disease, together with earlier studies and new experimental animal models, has provided important and novel insight into the molecular pathways involved in disease pathogenesis. Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD . Acronyms AR-JP: autosomal recessive juvenile-onset parkinsonism DA: dopaminergic DLB: dementia with Lewy bodies LB: Lewy body MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Pael-R: parkin-associated endothelin receptor-like receptor PD: Parkinson's disease PINK1: PTEN-induced putative kinase 1 ROS: reactive oxygen species SNc: substantia nigra pars compacta UCH-L1: ubiquitin carboxyl-terminal hydrolase L1 UPS: ubiquitin-proteasome system Most recent citing papers (via CrossRef)Modeling proteasome dynamics in Parkinson's disease Physical Biology 6(3):036005 (2009) Altered Platelet Monoamine Oxidase-B Activity in Idiopathic Parkinson’s Disease Neurochemical Research 34(8):1427-1432 (2009) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology Brain 132(7):1795-1809 (2009) Recent advances in our understanding of neurodegeneration Journal of Neural Transmission (2009)  RING Domain E3 Ubiquitin Ligases Annual Review of Biochemistry 78:399-434 (2009)
|
|
|
Users who read this review also read:
| C. W. Olanow and , W. G. Tatton Annual Review of Neuroscience. Volume 22, Page 123-144, Mar 1999 Abstract
| Full Text
| PDF (187 KB)
|
Add to Favorites
| Related | |
| Mark R. Cookson Annual Review of Biochemistry. Volume 74, Page 29-52, Jul 2005 Abstract
| Full Text
| PDF (301 KB)
|
Add to Favorites
| Related | |
| Kurt J. De Vos, Andrew J. Grierson, Steven Ackerley, Christopher C.J. Miller Annual Review of Neuroscience. Volume 31, Page 151-173, Jul 2008 Abstract
| Full Text
| PDF (1082 KB)
|
Add to Favorites
| Related | |
| Richard Mayeux Annual Review of Neuroscience. Volume 26, Page 81-104, Mar 2003 Abstract
| Full Text
| PDF (125 KB)
|
Add to Favorites
| Related | |
|
|